Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets

Buy Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets for Bulk Order

What is Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets?

Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets are a combination of Levocetrizine, an antihistamine, and Montelukast, a leukotriene receptor antagonist. This compound is classified within pharmacological categories used to treat allergic conditions and asthma.

In the pharmaceutical context, Levocetrizine is primarily utilized for the management of allergic rhinitis and chronic urticaria, while Montelukast is effective in preventing asthma attacks and addressing exercise-induced bronchoconstriction. Both compounds are essential in various therapeutic formulations aimed at improving patients’ quality of life.

This combination tablet holds regulatory significance as it is often prescribed in complex treatment regimens, necessitating compliance with health authorities’ guidelines to ensure safety and efficacy.

What Are the Applications of Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets?

• Management of allergic rhinitis and chronic urticaria.
• Prevention of asthma attacks and management of exercise-induced bronchoconstriction.
• Formulation for combination therapy in respiratory conditions.
• Research applications in pharmacological studies and clinical trials.

Why Choose Pharmint as Your Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets Supplier?

Pharmint offers unparalleled global sourcing capabilities for Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets. Our products come with comprehensive documentation, including Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), ensuring compliance with international regulatory standards.

We provide bulk availability, allowing for seamless procurement processes, and our efficient export support minimizes lead times, enhancing your supply chain’s reliability when compared to typical vendors.

Storage & Handling Guidelines for Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets

Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets should be stored in a cool, dry place, away from direct light and moisture. Optimal storage temperature is between 15°C to 30°C. Ensure that the product is kept in airtight packaging to maintain its integrity, especially for bulk or research-grade material.

Regulatory, Documentation & Export Information

This product is not classified as a controlled precursor; however, an end-use declaration may be required depending on jurisdiction. Available documents include COA and MSDS to ensure compliance with regulatory standards.

Levocetrizine 2.5 mg + Montelukast 4 mg DT Tablets FAQs

What are the key benefits of Levocetrizine + Montelukast combination?

This combination effectively manages allergic reactions and asthma, providing dual action for enhanced patient care.

How should Levocetrizine + Montelukast tablets be stored?

Store in a cool, dry place, away from direct light. Maintain at 15°C to 30°C in airtight packaging.

What documentation is required for procurement?

A Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) are essential for compliance and safety verification.

Can Levocetrizine + Montelukast be used in research?

Yes, this combination can be utilized in pharmacological studies and clinical research for efficacy evaluations.

What is Pharmint’s lead time for bulk orders?

Pharmint offers competitive lead times for bulk orders, enhancing supply chain efficiency and ensuring timely deliveries.